Pancreatic Cancer Research

Clinical trialNARecruiting

Using Tumour DNA and Proteins to Better Understand How Pancreatic Cancer Responds to Treatment

Accelerating the Actionability of Treatment in Resected and Locally Advanced Pancreatic Cancer

NCT06574620↗ ClinicalTrials.gov, retrieved 4 November 2026

Outcome
Ongoing
Phase
NA
Status
Recruiting
Study type
Interventional
Start
28 November 2025
Expected end
December 2031
Enrollment
200 participants
Sites
1
Primary outcomes
Frequency of comprehensive genomic results returned within 8 weeks of sample collection.
Sponsor
Other
Results posted
No
Last update
16 September 2026

These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.

Ask this document

Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess. Only its metadata is loaded so far, so most questions will be declined.

Try

Papers 21